quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:00:00·24d
PRRelease
Aquestive Therapeutics Inc. logo

Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film

AQST· Aquestive Therapeutics Inc.
Health Care
Original source

Companies

  • AQST
    Aquestive Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Jun 2UpdateOppenheimer$7.00
  • Dec 17UpdateCantor Fitzgerald$17.00
  • May 10UpdateLeerink Partners$8.00
  • Apr 11UpdatePiper Sandler$10.00
  • Mar 28UpdateRaymond James$7.00

Related

  • INSIDER10d
    SEC Form 4 filed by Barber Daniel
  • INSIDER10d
    SEC Form 4 filed by Boyd Peter E.
  • INSIDER10d
    SEC Form 4 filed by Jung Cassie
  • INSIDER10d
    SEC Form 4 filed by Toth A Ernest Jr
  • INSIDER10d
    SEC Form 4 filed by Korczynski Sherry
  • INSIDER10d
    SEC Form 4 filed by Braender Lori J
  • INSIDER13d
    SEC Form 3 filed by new insider Zalewski Thomas A.
  • SEC24d
    Aquestive Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022